Knowledge Center

Patent / Jan 01, 1984

Rhodium-containing catalysts and their application

Authors:
  • Philip Page
Source:
EP 86046

A catalyst for hydrogenating tetracycline intermediates was prepd. by treating a Rh phosphine complex with a hydrazine. Thus (Ph3P)3RhCl was treated with N2H4 to give a catalyst contg. 16.95% Rh which was used together with PPh3 to hydrogenate I (RR1 = CH2) to give I (R = Me, R1 = H) free from epimer.

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, ËÄÉ«AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

PowdAir, a simple capsule based inhaler

PowdAir is a simple, easy to use, capsule based dry powder inhaler with excellent performance.

Page
Read more

Membrane Technology

ËÄÉ«AV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more